p53 Lesions in Leukemic Transformation

被引:165
作者
Harutyunyan, Ashot [1 ]
Klampfl, Thorsten [1 ]
Cazzola, Mario [2 ]
Kralovics, Robert [1 ]
机构
[1] Ctr Mol Med, Vienna, Austria
[2] Univ Pavia, I-27100 Pavia, Italy
关键词
MYELOPROLIFERATIVE NEOPLASMS; MUTATIONS;
D O I
10.1056/NEJMc1012718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:488 / 490
页数:3
相关论文
共 5 条
[1]   Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms [J].
Green, Anthony ;
Beer, Philip .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04) :369-370
[2]   Deletions of the transcription factor Ikaros in myeloproliferative neoplasms [J].
Jaeger, R. ;
Gisslinger, H. ;
Passamonti, F. ;
Rumi, E. ;
Berg, T. ;
Gisslinger, B. ;
Pietra, D. ;
Harutyunyan, A. ;
Klampfl, T. ;
Olcaydu, D. ;
Cazzola, M. ;
Kralovics, R. .
LEUKEMIA, 2010, 24 (07) :1290-1298
[3]  
NA L, 2006, NATURE, V444, P61
[4]   LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations [J].
Pardanani, A. ;
Lasho, T. ;
Finke, C. ;
Oh, S. T. ;
Gotlib, J. ;
Tefferi, A. .
LEUKEMIA, 2010, 24 (10) :1713-1718
[5]   High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53 [J].
Veerakumarasivam, Abhi ;
Scott, Helen E. ;
Chin, Suet-Feung ;
Warren, Anne ;
Wallard, Matthew J. ;
Grimmer, Donna ;
Ichimura, Koichi ;
Caldas, Carlos ;
Collins, V. Peter ;
Neal, David E. ;
Kelly, John D. .
CLINICAL CANCER RESEARCH, 2008, 14 (09) :2527-2534